Muller TD, Finan B, Clemmensen C, DiMarchi RD, Tschop MH
- [USP Chapter 797: Pharmaceutical Compounding Sterile Preparations]( *United States Pharmacopeia*, 2023
Despite these restrictions, many patients prefer oral therapy over injections
Your clinician will individualize timing based on your baseline health, medication changes, and your response
PlexusDx offers both compounded tirzepatide injection (at $289/mo month-to-month, or from $249/mo on the 6-month plan) and oral tirzepatide (at $349/mo month-to-month, or from $279/mo on the 6-month plan) through licensed 503A compounding pharmacies, allowing patients to choose the delivery method that best suits their tolerance profile
Other agents in development include mazdutide , cagrilintide , survodutide, and orforglipron (an oral small-molecule GLP-1 agonist)